Coloma Jason V sold MAZE
September 1, 2026 · Form 4 insider transaction
Coloma Jason V sold 31,908 shares of Maze Therapeutics, Inc. at $26.29 per share, a transaction worth $838.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
31,908
Price
$26.29
Total value
$838.8K
InsiderColoma Jason V
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 1, 2026
Filing dateSeptember 3, 2026
Shares owned after223,355
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.555 per share, inclusive.; These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.